Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746259 · ClinicalTrials.gov registry record
FebriDx® Method Comparison Study Protocol
A clinical trial, sponsored by Lumos Diagnostics.
- Completed
- Registry status
- 800
- Enrollment target
NCT06746259 is a clinical trial that has completed, run by Lumos Diagnostics. The registered enrollment target is 800 participants.
The verdict
NCT06746259 has completed, sponsored by Lumos Diagnostics.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn about the performance and ease of use of FebriDx when operated by persons without laboratory experience or training in patients with acute respiratory symptoms. The main question it aims to answer is: • Is FebriDx accurate at differentiating bacterial from non-bacterial respiratory infections when used by untrained operators? Trained and untrained participants will run the FebriDx test on patients with respiratory symptoms to evaluate comparability.
Interventions
- DIAGNOSTIC_TEST Rapid point of care test to detect host immune response in ARI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2025-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06746259
The ClinicalTrials.gov registry entry for NCT06746259 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumos Diagnostics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapid point of care test to detect host immune response in ARI is the first listed.
NCT06746259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06746259 about?
NCT06746259 is a clinical study titled "FebriDx® Method Comparison Study Protocol". The goal of this observational study is to learn about the performance and ease of use of FebriDx when operated by persons without laboratory experience or training in patients with acute respiratory symptoms. The main question it aims to answer is: • Is FebriDx accurate at differentiating bacteria...
What is the current status of trial NCT06746259?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2024-12-20. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT06746259?
The interventions under investigation include: Rapid point of care test to detect host immune response in ARI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06746259?
This trial is sponsored by Lumos Diagnostics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.